Pharma & BioTech
Get smart on disease area market expectations with exclusive access to Wall Street analyst research and track clinical pipeline updates in real time from ClinicalTrials.gov, PubMed, and other leading pharma and biotech content sources.
Spend less time searching for specific data points with our AI search technology and extensive universe of private and public content sources—all in one place.
In this rapidly-growing and innovative sector, it’s crucial—now more than ever—to stay on top of market expectations and competitive landscapes. With Wall Street analyst research and expert calls, you can easily keep a pulse on market movements.
With thousands of content sources all in one place, including broker research and expert call transcripts, AlphaSense enables you to more easily track companies, clinical trials, and acquisitions, so you can deliver high-quality insights to your clients faster.
Life sciences use cases
Stay on top of clinical trial updates
Track and analyze clinical pipelines more easily with our aggregated universe of regulatory healthcare content from ClinicalTrials.gov, FDA, EMA, PubMed, and more.
Identify your market whitespace
Perform a more comprehensive competitor pipeline analysis and disease research to ensure you never miss out on updates with AI-powered company recognition and Search Summaries.
Evaluate market opportunities for BD&L
Accelerate the market landscaping process by quickly uncovering TAM, understanding the competitive landscape and core differentiators.
Accelerate your earnings research
Identify shifts in commentary, report on KPIs and themes competitors are discussing, surface emerging topics from industry leaders, and more.
Why the top 20 pharma companies trust AlphaSense
AlphaSense is a Leader in Market Intelligence on G2
Still not convinced? We’ve got more to show you
Find information faster and before it’s on anyone else’s radar
Start a free trial and search our extensive universe of public and private content—including company filings, event transcripts, news, trade journals, and equity research.